Methyl 4-nitro-1H-pyrrole-2-carboxylate, 97%, 100mg

2-Chloro-5-tert-butylbenzaldehyde, 1g

D-Cysteine hydrochloride, 98.0%, 500g

2-(9,9'-Spirobi[fluoren]-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 5g

3,4-Dihydro-2H-1,4-benzothiazine, 95.0%, 10g

(1-Ethylpiperidin-4-yl)methanamine dihydrochloride, 1g

Sample vials ROTILABO® with short thread ND9, Clear glass, with labelling space, 1.5 ml, 100 Piece(s)

3',6'-Dihydroxy-3-oxo-N-(prop-2-yn-1-yl)-3H-spiro[isobenzofuran-1,9'-xanthene]-5-carboxamide, 97.0%, 50mg

3,5-Dichlorophenylacetonitrile, 95.0%, 100g

1-Benzyl-2-((benzyloxy)methyl)-1H-imidazo[4,5-c]pyridine, 97%, 1g

(3-Aminophenyl)(imino)(methyl)-l6-sulfanone hydrochloride, 98%, 100mg

1-[4-(dimethylamino)phenyl]octahydro-4a(2H)-isoquinolinol hydrochloride, 95.0%, 1g

ETHYL N-(BENZYLOXY)CARBAMATE, 92.0%, 10g